1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
6 |
| Hold |
2 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2023 | |
|---|---|---|
| Revenue | 1.99M | - |
| Gross profit | -25.25M | 51,006.02% |
| Net profit | -34.27M | 51.72% |
| EBITDA | -34.15M | 50.14% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €185.56K |
Number of shares | 581K |
| Dividends | No |
Beta | 1.94 |
P/E ratio | -0.05 |
PEG ratio | 0.00 |
P/B ratio | -0.05 |
P/S ratio | 0.10 |
Company profile
| Name | Seelos Therapeutics Aktie |
| CEO | Raj Mehra |
| Employees | 8 |
Discover assets
Shareholders of Seelos Therapeutics Aktie also invest in the following assets
